Medical Xpress September 3, 2024
For many doctors and researchers, immunotherapy that uses someone’s own immune system to target and attack cancer cells is the next and best frontier of cancer treatment. Chimeric antigen receptor T-cell therapy, or CAR-T cell therapy, is one type of immunotherapy. Sometimes likened to a “smart drug” or “living drug,” CAR-T cell therapy relies on genetically modified immune cells to recognize and destroy cancer cells. In this expert alert, Richard Vile, Ph.D., an immunologist and cancer researcher at Mayo Clinic in Rochester, Minnesota, explains how CAR-T cell therapy works, including the benefits, risks and realities of treatment.
Over the last decade, immunotherapy-focused research has expanded, and results point toward promising, less arduous cancer treatments. Some immune system-focused drugs, for example,...
Today's Sponsors
Today's Sponsor